imino sugars (Enantigen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameimino sugars (Enantigen)
Drug Alias NamePBDNJ-0803CM-10-18PBDNJ-0801PBDNJ-0804CM-7-98
ClassificationSmall molecules
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnantigen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnantigen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A